新聞
其他
洞察力-諾和諾德如何誤讀美國減肥市場
諾和諾德就 Wegovy 的上市準備情況發出內部警告禮來的 Zepbound 在新增處方量上超過了 Wegovy諾和諾德的定價策略引起了保險公司和患者的反感Jacob Gronholt-Pedersen/Maggie Fick 路透哥本哈根7月1日 - 參與討論的六名前員工告訴路透記者，諾和諾德公司的高管們忽視了內部警告，即公司沒有為其減肥藥Wegovy的上市做好充分準備，導致這家丹麥製藥商在競爭對手禮來公司進入市場時處於更加弱勢的地位。自2021年中期Wegovy成為美國批準的首個高效肥胖症治療藥物以來，諾和諾德NOVOb.CO已經獲得了460億美元(2920億丹麥克朗) 的巨額淨利潤...路透社
7月1日 週二
加密貨幣
2 Tokens With Potential 10x Gains to Buy Now
The window is closing fast for early movers hunting down serious returns in the next bull cycle. Two tokens are standing out right now, and one of them is still flying under the radar. While Sui (SUI) holds a strong presence in the layer-1 market, the spotlight is shifting to Mutuum Finance (MUTM), a $0.03 […]Cryptopolitan
7月1日 週二
加密貨幣
Buffett Indicator hit 205%, signaling extreme market overvaluation
The Warren Buffett Indicator has climbed to 205%, the highest point ever tracked. That figure officially tops levels seen during both the Dot Com Bubble and the 2008 Financial Crisis. It means the total market cap of US stocks now sits at more than double the country’s GDP, marking the most expensive valuation on record. […]Cryptopolitan
7月1日 週二
商品
國際油市：石油因需求強勁的跡象而上漲；投資者等待OPEC+的決定
中國、沙特和俄羅斯的需求指標向好，石油價格上漲7月6日OPEC+召開會議，預計8月產量將增加41.1萬桶/日投資者也在關注美國貿易談判的進展路透紐約7月1日 - 油價周二走高，原因是投資者消化積極的需求指標，同時在OPEC+會議決定該組織8月份的產量政策之前保持謹慎。布蘭特原油 LCOc1收漲37美分，漲幅0.6%，報每桶67.11美元；美國原油 CLc1收漲34美分，漲幅約0.5%，報每桶65.45美元。美國石油經紀公司 Liquidity Energy 的風險情報專家 Randall Rothenberg 說，這些漲幅可能是由於中國一項民間調查的支持性數據，該數據顯示 6 月份工廠活動恢復...路透社
7月1日 週二
加密貨幣
Tension between President Donald Trump and Elon Musk blows up again this week
The tension between President Donald Trump and Tesla CEO Elon Musk blew up again this week. Elon called out the Republican-led tax bill as a disaster and even pushed for a brand-new political party. That same day, Trump fired back on Truth Social, saying it might be time to shut off every federal subsidy Elon’s […]Cryptopolitan
7月1日 週二
商品
芝加哥期市：大豆收盤持穩至微漲，豆油跳漲抵消作物長勢良好和玉米下跌影響
路透芝加哥7月1日 - 芝加哥期貨交易所(CBOT)大豆期貨周二收盤持穩至小幅上漲，交易商稱，因豆油價格跳漲支撐市場，抵消了美國作物狀況良好和玉米期貨下跌帶來的壓力。CBOT 8月大豆 SQ25收於每蒲式耳10.29-3/4美元，持平；新作11月合約 SX25收漲1/4美分，報每蒲式耳10.27-1/4美元。CBOT 8 月豆粕 SMQ25 跌至每短噸 272.60 美元的合約低點，收盤下跌 2.10 美元，報每短噸 273.70 美元。CBOT 8 月豆油 BOQ25 收盤上漲 1.01 美分，報收於每磅 53.66 美分。玉米期貨跌至合約低點，交易商稱，因美國作物生長狀況強勁，且預測美國中...路透社
7月1日 週二
加密貨幣
Lightchain AI Gets Trader Sentiment Without the Headlines—At the same time, Solana is having trouble with technical resistance
Solana is currently facing technical resistance, which has slowed its recent price rise. In the meantime, Lightchain AI is getting a sense of how traders feel without using flashy headlines or media hype. Lightchain AI is slowly gaining traction through organic interest and community support. It raised $20.9 million in its presale, and tokens […]Cryptopolitan
7月1日 週二
加密貨幣
This Crypto Has the Same Momentum as Ripple (XRP) Before Its Mega Pump That Turned $440 Into $154,020 in 2017
In 2017, an early Ripple (XRP) investor made news when they turned a little $440 investment into more than $154,000. At that time, XRP was just another low-cost cryptocurrency that no one noticed—until it wasn’t. Little Pepe (LILPEPE) could be the next big thing in crypto, following in the footsteps of other big things that […]Cryptopolitan
7月1日 週二
加密貨幣
Best Cryptos to Watch for Next Bull Run as Momentum Builds Fast
Momentum is building and the next crypto win isn’t waiting for anyone. As traders hunt for the best crypto to buy in 2025 Mutuum Finance (MUTM) is storming to the top of watchlists. Currently priced at $0.03 MUTM is moving fast through its presale phase. Mutuum Finance is in presale stage 5 of which 50% […]Cryptopolitan
7月1日 週二
股票
FDA 批準罕見基因療法試驗設計，Neurogene 公司一躍而起
7月1日 - ** 藥物開發商NeurogeneNGNE.O股價上漲35%至20.23美元 ** 周一晚些時候，Neurogene公司表示，它已獲得美國食品及藥物管理局（FDA）的批準， (link)，可以對3歲及以上女性進行NGN-401基因療法治療Rett綜合征的試驗設計。 ** 雷特綜合症是一種罕見的遺傳性疾病，會導致大腦在嬰兒期後停止正常發育，從而逐漸喪失運動、語言和協調能力。 ** 該試驗將是一項單臂、開放標簽研究，以患者為對照組 ** 公司表示，該試驗將招募約 18 名參與者，主要結果將在治療 12 個月後進行測量。 ** 截至 2025 年 3 月，該公司的可用現金為 2.92...路透社
7月1日 週二
加密貨幣
The SEC may streamline the ETF approval process
According to various reports on X, including from Eleanor Terrett, the SEC is currently trying to find ways to streamline the approval process for exchange-traded funds (ETFs), especially those related to cryptocurrency-related products. The agency, which just came under new leadership, has been swamped with crypto ETFs that need approval and has been criticized for […]Cryptopolitan
7月1日 週二
加密貨幣
Pepe and Pepeto Price Prediction: Will PEPE Hit $0.0001 in 2025?
Not only has Pepeto been stealing the headlines over the past few months since its official announcement, but it has also consistently hinted at yielding massive returns for investors who are willing to go big. However, despite Pepeto’s emergence, holders of Pepe predict its price could hit $0.001 in 2025. Does Pepe still have what […]Cryptopolitan
7月1日 週二
